Search Results
Vicore Pharma about the IPF clinical data recap and 2023 outlook
Interpreting the clinical trial designs and data of BioArctic, Vicore and BioInvent
Learn more about the AT2R - our target in IPF
Interview with Ahmed Mousa - The new CEO of Vicore Pharma
Vicore Pharma / “Tre triggers i närtid”
BioStock Life Science Fall Summit 2022 | Presentation: BioInvent
Trading Direkt Healthcare 2023-03-06 | Vicore Pharmas vd om kommande fas 2b-studien
Intervju med Surgical Science: "Det finns ett stort behov och vi har lyckats leverera"
Vicore Pharma - Presentation Erik Penser Bank - 3 juni 2021
Vicore Pharma gasar på med Covid19-studie